New Appointment to our Leadership Team !

Human Human behavior

24 April 2020


BlueReg Group is delighted to announce the appointment of Dominique Patrone as General Manager of PharmaBlue.


PharmaBlue is a French company, belonging to BlueReg Group, licensed as a Pharmaceutical company (“Exploitant”).


PharmaBlue partners with Global Healthcare Companies developing innovative medicinal products for unmet medical need in rare or serious diseases and offers a full platform to allow early commercialisation of these products in France.


Dominique holds a PharmD from the University of Montpellier and a Master’s degree in European Regulatory affairs. She is also a qualified quality auditor for the Pharmaceutical Industry.  Dominique has extensive regulatory, PV and quality management skills developed over 25 years in life science consultancies (Parexel & Quintiles)  as well as pharmaceutical companies (Expanscience, Baxter, Novex, Warner Chilcott, Amicus Therapeutics). 


”Dominique brings her considerable expertise and past experience to lead the effective functioning of PharmaBlue operations as well as to propose and implement strategies to develop our EU ambition for this unique BlueReg service offer.” said Corinne SCHMITZ CEO of BlueReg Group.


"I am very excited to join BlueReg and to lead PharmaBlue to the next phase of its development in Europe" said Dominique Patrone.


If you’d like to know more about the “Exploitant" status for the distribution of your medicines In France please visit or send us an email on :


Did you like this article? Share on social networks:

Associated News

BlueReg’s team will be pleased to meeting you at DIA EUROPE 2018 booth 56

BlueReg’s team will be pleased to meeting you at DIA EUROPE 2018 booth 56.  ...

Learn more

BlueReg continues to expand in the US opening its west coast operation in San Francisco, California

BlueReg, the consulting organization for life sciences companies, is announcing a development of its presence...

Learn more

UK BREXIT – eCTD BASELINE for Converting CAPs into UK MAs

From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be the UK’s stand-alone...

Learn more

Line - Organism